Viewing Study NCT01069692


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-02-03 @ 9:52 AM
Study NCT ID: NCT01069692
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2010-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hyperphosphatemia View
None Chronic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Kidney Disease View
None Hemodialysis View
None Hyperphosphatemia View
None Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis View